The University of Vermont Health Network Ventures and legal firm Wilson Sonsini Goodrich & Rosati recently invested in BioFactura’s $6M Series B Financing Round.
“With the commitment from the UVM fund and WSGR, BioFactura is now securing value-added institutional investors who bring significant financial and business resources to bear as we advance our biopharmaceutical products to the clinic,” said Darryl Sampey, BioFactura’s President and CEO.
{iframe}http://www.biofactura.com/university-of-vermont-health-network-ventures-and-wilson-sonsini-goodrich-rosati-invest-in-biofactura/{/iframe}